Int Ophthalmol Clin. 2023 Oct 1;63(4):93-101. doi: 10.1097/IIO.0000000000000499. Epub 2023 Sep 27.
Glaucoma drainage device (GDD) surgery has gained popularity as a treatment strategy for patients with medically uncontrolled glaucoma. Glaucoma is the leading cause of irreversible blindness in the world and continues to be a major public health issue. While our understanding of glaucoma continues to evolve, the primary treatment for glaucoma continues to be intraocular pressure (IOP) control. When medical treatment fails, glaucoma surgery is considered. GDD implantation is one of the most commonly performed incisional glaucoma surgeries. GDD was originally designed for patients with secondary glaucoma and/or patients who are at an increased risk of failure after trabeculectomy. More recently, its application has been extended to primary glaucoma as the first choice of incisional surgery. This manuscript summarizes recent GDD types, implantation, clinical outcome and complications.
青光眼引流装置 (GDD) 手术已成为治疗药物无法控制的青光眼患者的一种受欢迎的治疗策略。青光眼是全球导致不可逆性失明的主要原因,仍是一个重大的公共卫生问题。尽管我们对青光眼的认识不断发展,但青光眼的主要治疗方法仍然是眼压 (IOP) 控制。当药物治疗失败时,就会考虑进行青光眼手术。GDD 植入是最常进行的切开性青光眼手术之一。GDD 最初是为继发性青光眼和/或小梁切除术失败风险增加的患者设计的。最近,它的应用已扩展到原发性青光眼,成为切开性手术的首选。本文总结了最近的 GDD 类型、植入、临床结果和并发症。